Nanoviricides Inc’s (NYSEMKT:NNVC) Sentiment is 2

Nanoviricides Inc’s Sentiment

In 2018 Q2 Nanoviricides Inc (NYSEMKT:NNVC) big money sentiment increased to 2, according to SEC.gov filings. So its up 1.00, from 2018Q1’s 1. 12 active investment managers increased and opened new equity positions, while 6 reduced and sold their holdings in Nanoviricides Inc so the sentiment improved. Funds own 3.64 million shares, up from 3.49 million shares in 2018Q1. Funds holding Nanoviricides Inc in top 10 was flat from 0 to 0 for the same number . 2 Investors Sold All; 4 Reduced Holdings; 7 increased stakes while 5 active investment managers bought stakes.

Significant Nanoviricides Inc Investors

As of 2018 Q2 Pioneer Trust Bank N A Or has 0.02% invested in Nanoviricides Inc. As of 2018 Q2, 363,513 shares of Nanoviricides Inc are owned by Wharton Business Group Llc. Bank Of America Corp De reported 15,817 shares. Bank Of New York Mellon Corp revealed 39,349 shares position in Nanoviricides Inc. The Ohio-based fund Bartlett & Co. Llc holds 40,714 shares or 0% of their US equity exposure.

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections.The company has $25.50 million market cap. The firm is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus drug candidate that could enable a functional cure for HIV/AIDS.Currently it has negative earnings. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses.

NNVC is hitting $0.3675 during the last trading session, after increased 5.00%.NanoViricides, Inc. has volume of 37,778 shares. Since December 8, 2017 NNVC has declined 72.63% and is downtrending. NNVC underperformed by 88.25% the S&P 500.

175,983 are owned by Geode Mngmt Ltd Liability Corporation. Sei Invs accumulated 7,202 shs. Jpmorgan Chase And has invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). North Star Investment invested in 0% or 6,000 shs. Raymond James Fincl Services Advsrs has invested 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Bancorporation Of America De owns 15,817 shs for 0% of their capital. Wharton Business Gp Ltd Liability has invested 0.02% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Morgan Stanley reported 10,223 shs. Rathbone Brothers Public Ltd Com holds 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC) or 28,250 shs. Blackrock owns 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 40,093 shs. Us National Bank De has 86 shs for 0% of their capital. State Street owns 15,900 shs for 0% of their capital. Deutsche Comml Bank Ag stated it has 227,676 shs or 0% of all its holdings. 60,000 are owned by Staley Advisers. Bartlett And Ltd Liability Company has 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 40,714 shs.

For more NanoViricides, Inc. (NYSEAMERICAN:NNVC) news posted recently go to: Twst.com, Twst.com, Twst.com, Twst.com or Twst.com. The titles are as follows: “Fresh Del Monte Produce Inc.: Fresh Del Monte Produce Inc. Reports Third Quarter 2018 Financial Results – The Wall Street Transcript” posted on October 30, 2018, “Vipshop Holdings Limited: Vipshop Holdings Limited to Hold 2018 Annual General Meeting on December 11, 2018 – The Wall Street Transcript” on November 06, 2018, “GOL Linhas Aéreas Inteligentes SA: Third Quarter of 2018 Earnings Release – The Wall Street Transcript” with a publish date: November 01, 2018, “Humana Inc.: Humana Reports Third Quarter 2018 Financial Results; Raises Full Year 2018 Adjusted EPS Guidance – The Wall Street Transcript” and the last “Interview with the CEO and the President and Chairman: NanoViricides, Inc. (NYSEAMERICAN:NNVC) – The Wall Street Transcript” with publication date: October 23, 2018.

NanoViricides, Inc. (NYSEAMERICAN:NNVC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.